CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 38.418
EU - Europa 20.806
AS - Asia 19.837
SA - Sud America 3.683
AF - Africa 240
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 20
Totale 83.031
Nazione #
US - Stati Uniti d'America 38.110
GB - Regno Unito 8.947
CN - Cina 7.068
SG - Singapore 5.476
HK - Hong Kong 3.650
BR - Brasile 3.020
IT - Italia 2.576
DE - Germania 2.193
SE - Svezia 1.868
UA - Ucraina 1.813
VN - Vietnam 1.231
FI - Finlandia 957
RU - Federazione Russa 926
TR - Turchia 876
BG - Bulgaria 659
KR - Corea 593
AR - Argentina 273
FR - Francia 264
ID - Indonesia 192
IN - India 181
MX - Messico 129
EC - Ecuador 126
BD - Bangladesh 115
NL - Olanda 102
CA - Canada 97
ZA - Sudafrica 82
IQ - Iraq 76
IE - Irlanda 75
PL - Polonia 71
CO - Colombia 68
ES - Italia 66
LT - Lituania 52
VE - Venezuela 52
MA - Marocco 47
IR - Iran 46
JP - Giappone 44
CL - Cile 43
PY - Paraguay 41
BE - Belgio 33
PK - Pakistan 32
UZ - Uzbekistan 29
EG - Egitto 28
MY - Malesia 26
PE - Perù 26
KE - Kenya 25
EU - Europa 24
AE - Emirati Arabi Uniti 23
CH - Svizzera 22
PT - Portogallo 21
SA - Arabia Saudita 21
DO - Repubblica Dominicana 19
AU - Australia 17
IL - Israele 17
JM - Giamaica 17
RO - Romania 17
UY - Uruguay 17
AZ - Azerbaigian 16
PH - Filippine 16
AL - Albania 15
TN - Tunisia 15
AT - Austria 14
BO - Bolivia 14
KZ - Kazakistan 14
NP - Nepal 13
CZ - Repubblica Ceca 12
DK - Danimarca 12
GR - Grecia 12
JO - Giordania 12
SI - Slovenia 12
OM - Oman 11
CR - Costa Rica 9
DZ - Algeria 9
HN - Honduras 9
HR - Croazia 9
RS - Serbia 9
BY - Bielorussia 8
HU - Ungheria 8
PA - Panama 8
KG - Kirghizistan 7
BA - Bosnia-Erzegovina 6
NG - Nigeria 6
AM - Armenia 5
BB - Barbados 5
CY - Cipro 5
KW - Kuwait 5
LB - Libano 5
LV - Lettonia 5
LY - Libia 5
BH - Bahrain 4
CI - Costa d'Avorio 4
ET - Etiopia 4
GE - Georgia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
EE - Estonia 3
MD - Moldavia 3
MK - Macedonia 3
MT - Malta 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
Totale 82.972
Città #
Southend 7.074
Jacksonville 4.031
Santa Clara 3.785
Hong Kong 3.632
Fairfield 3.613
Singapore 3.378
Dearborn 2.598
Hefei 2.590
Woodbridge 2.280
Ashburn 2.228
Chandler 2.083
Houston 1.743
Wilmington 1.472
London 1.393
Beijing 1.311
Ann Arbor 1.232
Seattle 1.224
Cambridge 1.149
Nyköping 1.120
Princeton 758
Sofia 655
Eugene 640
Modena 606
Seoul 554
Los Angeles 535
Ho Chi Minh City 480
The Dalles 451
Dallas 435
Izmir 426
Bremen 423
Chicago 379
Buffalo 378
San Diego 370
Helsinki 310
New York 273
Shanghai 270
São Paulo 265
Hanoi 242
Moscow 237
Des Moines 185
Council Bluffs 176
Milan 160
Salt Lake City 147
Rome 113
Norwalk 105
Guangzhou 103
Kunming 87
Rio de Janeiro 83
San Jose 78
Jakarta 77
Nanjing 77
Dublin 73
Columbus 69
Tampa 68
Elk Grove Village 62
Belo Horizonte 59
Curitiba 56
Munich 53
Brasília 52
Haiphong 51
San Mateo 50
Boardman 46
Quito 45
Da Nang 44
Bologna 43
Falls Church 43
Guayaquil 41
Jinan 41
Redwood City 41
Mexico City 40
Verona 40
Dongguan 38
Campinas 36
Frankfurt am Main 36
Goiânia 35
Johannesburg 34
Nanchang 34
Atlanta 33
Changsha 33
Grafing 32
San Francisco 32
Thái Bình 32
Biên Hòa 31
Brooklyn 31
Porto Alegre 31
Tokyo 31
Augusta 30
Kraków 30
Amsterdam 29
Tashkent 29
Warsaw 29
Wuhan 29
Lancaster 28
Sterling 28
Hải Dương 27
Buenos Aires 26
Phoenix 26
Ribeirão Preto 26
Salvador 26
Shenyang 26
Totale 59.919
Nome #
Intensity of menstrual pain and estimated angle of uterine flexion 385
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 366
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 343
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 318
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 313
Association between urinary incontinence and climacteric symptoms in postmenopausal women 294
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 292
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 288
Adenomyosis of the Extrapelvic Portion of the Round Ligament 283
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 280
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 278
Intermenstrual pelvic pain, quality of life and mood 277
Recommendations for contraception in women with diabetes. AMD-SIC position paper 269
Folate administration decreases oxidative status and blood pressure in postmenopausal women 263
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 263
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 262
Metabolic impact of combined hormonal contraceptives containing estradiol 257
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 255
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 250
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 250
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 249
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 249
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 246
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 244
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 243
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 243
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 240
Season of birth influences the timing of menopause 240
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 238
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 237
Pharmacokinetic evaluation of desogestrel as a female contraceptive 234
Medical and patient attitude towards vaginal atrophy: the AGATA study 233
Melatonin in relation to physiology in adult humans 232
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 231
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 230
Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 230
A role for melatonin in PCOS? 229
Continuous combined hormone replacement therapy with oral 17β-estradiol and norethisterone acetate improves homocysteine metabolism in postmenopausal women 228
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women 227
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women 220
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 220
Role of melatonin in circadian rhythm at menopause 219
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 218
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 218
Amplification of pulsatile LH secretion by exogenous melatonin in women. 217
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 216
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 214
Anello Contraccettivo: i vantaggi della somministrazione vaginale 211
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 211
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 211
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 210
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 209
Prevalence of menstrual pain in young women: What is dysmenorrhea? 208
Seasonal trend of acute pelvic inflammatory disease 208
Influence of melatonin and photoperiod on animal and human reproduction 207
Prolonged melatonin administration decreases nocturnal blood pressure in women 207
Vaginal atrophy of women in postmenopause. Results from amulticentric observational study: The AGATA study 207
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 205
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 205
Pharmacological, metabolic and clinical aspects of new oral contraceptive associations containing natural estrogens [Aspetti farmacologici, metabolici e clinici delle nuove associazioni contraccettive a base di estrogeni naturali] 204
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 204
Amplification of pulsatile LH secretion by exogenous melatonin in women 202
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 200
Ovary Cystadenofibroma Associated with Didelphys Uterus in a Teenager: Conservative Laparoscopic Management 199
Drospirenone: dati di sicurezza a lungo termine 199
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 198
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 198
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 196
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 196
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women 195
Effetti dell’ HRT e SERM sulla pressione arteriosa 195
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 194
Fattori implicati nel determinismo del sesso del nascituro 193
Hormone replacement therapy and glucose metabolism 193
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 193
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 192
Conseguenze dell'Isterectomia associata o no ad ovariectomia nella donna 192
The effect of menopause on blood lipid and lipoprotein levels 192
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 192
Nutrition, Nutriceuticals in older women. 191
Estrogeni e ossido nitrico: un sinergismo. 191
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 191
A comparison of the central effects of different progestins used in hormone replacement therapy 191
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 190
Contraccettivi con soli progestinici in perimenopausa.Effetti sul dispendio energetico e composizione corporea 190
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 190
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 189
Correlazione tra i livelli di omocisteina e densità minerale ossea in donne in postmenopausa. Uno studio longitudinale 189
Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen 188
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 186
Tibolone and estradiol plus norethisterone acetate similarly influence endothelium-dependent vasodilatation in healthy postmenopausal women 184
The effect of tibolone on 24h blood pressure and heart rate 183
Effetto di una terapia ormonale sostitutiva combinata continua contenente noretisterone acetato e del tibolone sulla pressione arteriosa delle 24 h ore 183
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 183
Dienogest mediates midkine suppression in endometriosis 183
Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause. 182
Oral contraceptives and insulin sensitivity 182
Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women. 180
Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women. 180
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 180
Totale 22.363
Categoria #
all - tutte 327.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 327.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.918 0 0 0 0 0 0 966 1.038 257 1.005 356 296
2021/20226.963 130 1.273 483 459 142 334 250 390 941 573 704 1.284
2022/20236.690 972 573 365 449 1.184 1.018 125 616 891 60 225 212
2023/20244.666 201 264 198 332 1.266 515 622 569 74 59 117 449
2024/202515.613 486 186 115 1.142 3.078 2.003 936 720 2.249 1.091 1.169 2.438
2025/202615.395 1.457 1.520 3.988 4.026 2.537 1.818 49 0 0 0 0 0
Totale 83.584